Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine for Postoperative Pain and Cognitive Dysfunction
NCT04643132Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in postoperative pain and Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Mechanical hyperalgesia threshold on the palms of feet. Status: unknown.
02
Drugs
esketamine
03
Conditions
postoperative painPost-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT04643132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643132.